Garo H Armen
CIK 935679 · EXEC. CHAIR & PRINCIPAL OFF · last filed 2026-08-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AGEN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
LEXINGTON, MA 02421
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Protagenic Therapeutics, Inc.\new (PTIX) Delisted | EXEC. CHAIR & PRINCIPAL OFF | 73,533 | $0.50 | $36.8K | $32.0K | 8 | 2026-08-24 |
| AGEN | See Remarks | 402,406 | $6.32 | $2.54M | $7.81M | 259 | 2026-08-12 |
| Protagenic Therapeutics, Inc.\new (PTIXW) Delisted | Executive Chairman | — | $0.01 | — | $0 | 1 | 2024-03-29 |
| INKT | Director | 196,640 | $10.41 | $2.05M | $0 | 4 | 2023-05-26 |
| AGENUS INC (AGEND) Delisted | Chairman & CEO | 1,746,471 | — | — | $49.8K | 1 | 2011-10-03 |
| COLOR KINETICS INC (CLRK) Delisted | Director | 0 | — | — | $0 | 4 | 2007-08-27 |
Recent Filings · Page 5 of 29
281 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-20 | AGEN | Grant (A) | +4,700 | $16.4K | EDGAR |
| 2025-05-05 | AGEN | Grant (A) | +5,260 | $16.4K | EDGAR |
| 2025-04-22 | AGEN | Grant (A) | +7,886 | $16.4K | EDGAR |
| 2025-04-08 | AGEN | Grant (A) | +10,288 | $16.0K | EDGAR |
| 2025-03-24 | AGEN | Grant (A) | +9,243 | $14.9K | EDGAR |
| 2025-03-11 | AGEN | Grant (A) | +6,332 | $14.9K | EDGAR |
| 2025-02-25 | AGEN | Grant (A) | +4,483 | $14.9K | EDGAR |
| 2025-02-11 | AGEN | Grant (A) | +4,251 | $14.9K | EDGAR |
| 2025-01-28 | AGEN | Grant (A) | +4,169 | $14.9K | EDGAR |
| 2025-01-13 | AGEN | Grant (A) | +4,777 | $14.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.